Science Explorer Back to mapMap
Discussion
Topic · Genetics

Vascular Anomalies and Treatments

Vascular Anomalies and Treatments is a research topic within Genetics. Science Explorer counts 15k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and management of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder characterized by vascular malformations. It covers topics such as genetics, pulmonary arteriovenous malformations, embolization, epistaxis, liver involvement, SMAD4 mutations, and vascular anomalies.

  • Hereditary Hemorrhagic Telangiectasia
  • Diagnosis
  • Management
  • Genetics
  • Pulmonary Arteriovenous Malformations
  • Embolization
  • Epistaxis
  • Liver Involvement
  • SMAD4 Mutations
  • Vascular Anomalies
Research works
15k
fractional, since 1950
In the world top 10%
1.6k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+12%
the tick is no change
Largest producer
United States
35% of the 10 largest, 2022-now
Vascular Anomalies and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Vascular Anomalies and Treatments research?

By volume, the United States and China publish the most (900 and 480 works in 2022-now).

By volume, 2022-now

  1. 1 United States 900 works
  2. 2 China 480 works
  3. 3 Japan 294 works
  4. 4 India 239 works
  5. 5 United Kingdom 127 works
  6. 6 Germany 124 works
  7. 7 France 119 works
  8. 8 Italy 96 works
  9. 9 Türkiye 92 works
  10. 10 Spain 85 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 35.2%China: 18.8%Japan: 11.5%India: 9.4%6 others listed: 25.1%35%largest
United States900 · 35.2%China480 · 18.8%Japan294 · 11.5%India239 · 9.4%6 others listed642 · 25.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Vascular Anomalies and Treatments research?

By volume in 2022-now, Harvard University publishes the most Vascular Anomalies and Treatments research, followed by Mayo Clinic and All India Institute of Medical Sciences.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 42 works
  2. 2 Mayo ClinicUnited States 29 works
  3. 3 All India Institute of Medical SciencesIndia 28 works
  4. 4 Capital Medical UniversityChina 22 works
  5. 5 Shanghai Jiao Tong UniversityChina 21 works
  6. 6 Sichuan UniversityChina 21 works
  7. 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 17 works
  8. 8 Johns Hopkins UniversityUnited States 17 works
  9. 9 University of TorontoCanada 14 works
  10. 10 University of North Carolina at Chapel HillUnited States 14 works

Who are the leading researchers in Vascular Anomalies and Treatments?

The most-cited researchers publishing on Vascular Anomalies and Treatments include Gregory Y.H. Lip, Valentı́n Fuster and Patrizio Lancellotti.

  1. 1 Gregory Y.H. Lip United Kingdom 311k citations
  2. 2 Valentı́n Fuster United States 257k citations
  3. 3 Patrizio Lancellotti Belgium 245k citations
  4. 4 Clifford R. Jack United States 218k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Vascular Anomalies and Treatments?

The most cited paper in Vascular Anomalies and Treatments is "Haemodynamic definitions and updated clinical classification of pulmonary hypertension" (Gérald Simonneau, David Montani, David Stephen Celermajer et al., 2018), with 3,872 citations. Next come "Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension" (2,489) and "ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension" (2,369).

Most cited papers
#PaperReleasedCitations
1 Haemodynamic definitions and updated clinical classification of pulmonary hypertension Gérald Simonneau, David Montani, David Stephen Celermajer et al. · European Respiratory Journal Open access 13 Dec 2018 3,872
2 Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension Nazzareno Galiè, Hossein Ardeschir Ghofrani, Adam Torbicki et al. · New England Journal of Medicine Open access 16 Nov 2005 2,489
3 ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch et al. · Journal of the American College of Cardiology Open access Apr 2009 2,369
4 Updated Clinical Classification of Pulmonary Hypertension Gérald Simonneau, Ivan M. Robbins, Maurice Beghetti et al. · Journal of the American College of Cardiology Open access Jun 2009 2,097
5 Clinical classification of pulmonary hypertension Gérald Simonneau, Nazzareno Galiè, Lewis J. Rubin et al. · Journal of the American College of Cardiology Open access Jun 2004 1,906
All 100 most cited papers, with filters and sorting

Where is Vascular Anomalies and Treatments research done?

The largest centres of Vascular Anomalies and Treatments research in 2022-now are Beijing (China), Tokyo (Japan), Paris (France) and Shanghai (China).

Largest cities, 2022-now

  1. 1 BeijingChina 79 works
  2. 2 TokyoJapan 53 works
  3. 3 ParisFrance 46 works
  4. 4 ShanghaiChina 43 works
  5. 5 LondonUnited Kingdom 39 works
  6. 6 New DelhiIndia 37 works
  7. 7 BostonUnited States 36 works
  8. 8 SeoulSouth Korea 31 works
  9. 9 New YorkUnited States 31 works
  10. 10 BaltimoreUnited States 29 works
See Vascular Anomalies and Treatments on the map

Where is the best place to study Vascular Anomalies and Treatments?

Among universities, judged by research, Harvard University, Sorbonne Université and University of Chicago score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 20.58%fractional works in this field (log) →share of work in the world top 10% →University of ChicagoSorbonne UniversitéUniversité Paris CitéHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 88.419.5%4.3×42 +17.8%
2Sorbonne UniversitéFrance 62.322.4%5.0×10 +67.7%
3University of ChicagoUnited States 62.028.9%3.9×10 +230.8%
4Université Paris CitéFrance 59.521.6%4.5×10 +56.5%
5Shanghai Jiao Tong UniversityChina 59.416.7%2.4×21 +19.9%
6Yale UniversityUnited States 59.322.5%4.0×13 +3.1%
7University of TorontoCanada 58.918.3%2.3×14 -12.2%
8Capital Medical UniversityChina 55.016.7%6.6×22 +5.9%
9Seoul National UniversitySouth Korea 51.026.3%2.6×9 +3.4%
10University of California, San FranciscoUnited States 50.912.9%5.5×12 +3.5%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Vascular Anomalies and Treatments, country by country

Is Vascular Anomalies and Treatments research growing?

Output in 2022-2025 was 12% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Vascular Anomalies and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vascular Anomalies and Treatments as a percentage of every work published that year, 0.013% in 2024.

still counting0.010%0.020%Vascular Anomalies and Treatments0.015% in 202519801990200020102020

Fractional works of Vascular Anomalies and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Vascular Anomalies and Treatments10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Vascular Anomalies and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.